Second-line antituberculosis drug exposure thresholds predictive of adverse events in multidrug-resistant tuberculosis treatment.
Wang S, Forsman LD, Xu C, Zhang H, Zhu Y, Shao G, Wang S, Cao J, Xiong H, Niward K, Schön T, Bruchfeld J, Zhu L, Alffenaar JW, Hu Y.
Wang S, et al. Among authors: xiong h.
Int J Infect Dis. 2024 Mar;140:62-69. doi: 10.1016/j.ijid.2024.01.001. Epub 2024 Jan 3.
Int J Infect Dis. 2024.
PMID: 38176643
Free article.